Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Nextensa SA is a public regulated real estate company (RREC) functioning as a mixed-use real estate investor and developer, headquartered in Brussels, Belgium. It owns and manages a diversified portfolio of properties, including retail (42%), offices (39%), and logistics/semi-industrial assets (19%), with a total leasable area of 382,335 m² and a book value of €1.215 billion as of the end of 2024. Geographically, the investment portfolio spans the Grand Duchy of Luxembourg (43%), Belgium (42%), and Austria (15%), generating steady rental income across these regions. As a developer, Nextensa focuses on large-scale urban projects like the Tour & Taxis redevelopment in Brussels, creating over 350,000 m² of mixed residential, office, and leisure spaces, and the Cloche d'Or extension in Luxembourg, exceeding 400,000 m² of offices, retail, and housing. Originally founded as Leavinvest Real Estate in 1988, it evolved through strategic acquisitions, divestments, and a 2021 consolidation into a developer, emphasizing sustainable, inclusive environments that contribute to community well-being and environmental goals. With 24 full-time equivalents and listed on Euronext Brussels, Nextensa plays a key role in shaping vibrant, future-oriented real estate markets in Europe.
€47.30
+€0.01 (+0.01%)
EOD Jun 23, 2026 · Twelve Data
34.39% operating margin is above average. ROIC at 1.87%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue declined 8.2% YoY. Margins deteriorated 8.9pp alongside, both lines moving the wrong way.
Free cash flow declined 4109% versus the prior year, cash generation momentum has weakened. Negative free cash flow of -€82M. The business is consuming cash, not generating it.
14.5x earnings. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€124M
▼ -8.2% YoY
Net Income (TTM)
€33M
▲ +395.0% YoY
Op. Margin
34.39%
▼ -8.9pp YoY
ROIC
1.87%
▼ -1.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€82M
▼ -4108.6% YoY
Op. Cash Flow (TTM)
-€80M
▼ -3969.9% YoY
Net Debt
€593M
Cash & Equiv.
€6M
3Y CAGR: -3.5%
Continue Research
At a P/E of 14.5, Nextensa SA (NEXTA.XBRU)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Nextensa SA scores 26/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Nextensa SA scores 26 out of 100 on Intrinsiqq's quality score, passing 2 of 7 checks, which makes it a lower-quality business on these measures. Recent fundamentals include a 34.4% operating margin and a 1.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh NEXTA.XBRU's valuation and scores 26/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.